Mutant KRAS drives metabolic reprogramming and autophagic flux in premalignant pancreatic cells

[1]  M. Otsuka,et al.  The biological role of metabolic reprogramming in pancreatic cancer , 2020, MedComm.

[2]  X. Brannmjk.  Capillary , 2020, Definitions.

[3]  Davide Risso,et al.  Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition , 2020, Nature.

[4]  A. Balmain,et al.  KRAS4A directly regulates hexokinase 1 , 2019, Nature.

[5]  D. Bar-Sagi,et al.  Plasma membrane v-ATPase controls oncogenic Ras-induced macropinocytosis , 2019, Nature.

[6]  S. C. Chafe,et al.  Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. , 2019, Gastroenterology.

[7]  S. Gulati,et al.  Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer , 2019, Scientific Reports.

[8]  S. Hanash,et al.  Syndecan1 is a critical mediator of macropinocytosis in pancreatic cancer , 2019, Nature.

[9]  E. Petricoin,et al.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer , 2019, Nature Medicine.

[10]  D. Merico,et al.  Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. , 2019, Cancer cell.

[11]  J. Yap,et al.  Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers , 2019, Nature Medicine.

[12]  B. Garcia,et al.  Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis. , 2019, Cancer discovery.

[13]  A. Levine,et al.  The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters. , 2019, Cancer cell.

[14]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[15]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[16]  R. Bronson,et al.  Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis , 2018, Nature Communications.

[17]  Kwok-Kin Wong,et al.  Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. , 2018, Cancer discovery.

[18]  Charles M. Perou,et al.  Asparagine bioavailability governs metastasis in a model of breast cancer , 2018, Nature.

[19]  R. White,et al.  As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid. , 2018, Cell metabolism.

[20]  P. Zarrinkar,et al.  Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor , 2018, Cell.

[21]  Mathias J Friedrich,et al.  Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes , 2018, Nature.

[22]  A. Aloisi,et al.  Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells. , 2017, Free radical biology & medicine.

[23]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.

[24]  M. V. Vander Heiden,et al.  Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions , 2017, Nature Communications.

[25]  Frank McCormick,et al.  RAS Proteins and Their Regulators in Human Disease , 2017, Cell.

[26]  Jiahuai Han,et al.  Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis. , 2017, Gastroenterology.

[27]  C. Lyssiotis,et al.  Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. , 2017, Cancer cell.

[28]  Y. Bhutia,et al.  Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer , 2016, British journal of pharmacology.

[29]  D. Hayes,et al.  LKB1 loss links serine metabolism to DNA methylation and tumorigenesis , 2016, Nature.

[30]  Suguru Hasegawa,et al.  Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase12 , 2016, Neoplasia.

[31]  L. Cantley,et al.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.

[32]  Chi V. Dang,et al.  From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.

[33]  T. Graeber,et al.  Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor , 2016, Nature Communications.

[34]  L. Postovit,et al.  A Digital PCR-Based Method for Efficient and Highly Specific Screening of Genome Edited Cells , 2016, PloS one.

[35]  P. Storz,et al.  Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions. , 2016, Cell reports.

[36]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[37]  Neal Rosen,et al.  Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism , 2016, Science.

[38]  C. Martins,et al.  Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities , 2016, Nature.

[39]  T. Horvath,et al.  Mitochondrial ROS Signaling in Organismal Homeostasis , 2015, Cell.

[40]  Martin L. Miller,et al.  Mitochondrial DNA copy number variation across human cancers , 2015, bioRxiv.

[41]  J. Kench,et al.  Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.

[42]  Lorenzo Galluzzi,et al.  Metabolic Control of Autophagy , 2014, Cell.

[43]  R. Finn,et al.  KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition , 2014, British Journal of Cancer.

[44]  Dihua Yu,et al.  Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis , 2014, PloS one.

[45]  Gerald C. Chu,et al.  Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. , 2014, Cancer discovery.

[46]  Amy Y. M. Au,et al.  p53 status determines the role of autophagy in pancreatic tumour development , 2013, Nature.

[47]  Tomer Shlomi,et al.  Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia , 2013, Molecular systems biology.

[48]  Christian M. Metallo,et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.

[49]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[50]  N. Sunaga,et al.  Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer , 2012, British Journal of Cancer.

[51]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[52]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[53]  Masaaki Komatsu,et al.  Autophagy: Renovation of Cells and Tissues , 2011, Cell.

[54]  D. Bar-Sagi,et al.  RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.

[55]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[56]  M. Tomita,et al.  Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles , 2009, Metabolomics.

[57]  Jeffrey P. MacKeigan,et al.  Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.

[58]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[59]  E. Ren.  Know the enemy , 2006, Nature Biotechnology.

[60]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[61]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[62]  R H Hruban,et al.  Progression model for pancreatic cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[63]  T. Soga,et al.  Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. , 2000, Analytical chemistry.

[64]  K. Oh,et al.  A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. , 1996, Biochimica et biophysica acta.

[65]  M. Iannuzzi,et al.  A cystic fibrosis pancreatic adenocarcinoma cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[66]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[67]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.